CMTAreportSummer2022web

…quite strong compared to the beginning of treatment. I always used a handrail going up and down stairs before treatment, but now I walk up and down with some pace…

CMTAreportSummer2022web

…quite strong compared to the beginning of treatment. I always used a handrail going up and down stairs before treatment, but now I walk up and down with some pace…

CMTAfall2022web

…virtual meeting June 7. Mackenzie shared valuable information on treatment goals for bracing, treatment options, who’s a candi- date, what to expect at a visit and much more. The branch…

CMTAfall2022web

…virtual meeting June 7. Mackenzie shared valuable information on treatment goals for bracing, treatment options, who’s a candi- date, what to expect at a visit and much more. The branch…

CMTAreportSpring2023spreads

…CMTA Partner On ASO Treatment for CMT1A 2023 ‘Pivotal’ Year for PXT3003 Treatment For CMT1A as Manufacturing Shifts to U.S. CMTA partner Pharnext announced Jan. 26 that it has completed…

A New Therapeutic Strategy for CMT2D

…for nerve cell survival. Through experiments that identified the cause of this transport disruption, the scientists were able to develop a treatment strategy that improves this critical transportation system in…

Clinical Summit 2023 – Impact Report

…increasing levels of disability. CMT affects around 1 in every 2500 people, there are over 100 known causative gene mutations and there is currently no curative treatment available to the…

CMTA Announces New Center of Excellence in the United Kingdom

The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research aimed at bringing treatments to patients and improving the lives of those living with Charcot-Marie-Tooth disease…

CMT2S Research

…using mouse models of several forms of CMT to determine which types may be candidates for treatment with HDAC6 inhibitors and whether HDAC6 inhibitors may be of therapeutic benefit across…